Sera Prognostics Inc Class A

Research Sera Prognostics Inc Class A (SERA) on Bullrun: market cap USD 70.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSERA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 70.88M
• Financial periodFY2025
• RevenueUSD 81.00K
• Revenue growth5.2%
• Net income-USD 31.93M
• Free cash flow-USD 26.35M
• Gross margin-102.5%

Valuation Snapshot

latest market cap is USD 70.88M.

About Sera Prognostics Inc Class A

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation.

Frequently asked questions

What is Sera Prognostics Inc Class A's market cap?

Sera Prognostics Inc Class A's market capitalization is USD 70.88M.

What does Sera Prognostics Inc Class A do?

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States.